CompaniesIverson Genetics

Iverson Genetics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

88

By Phase

PHASE1: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
NCT01022255
Hover over trial bars to see details

Recent Trials

NCT05508178Lead Sponsor
Recombinant, Bivalent, Norovirus Vaccine Study
PHASE1Completed
60 participants
Started: Aug 17, 2020 · Completed: Oct 26, 2021
NCT01022255Lead Sponsor
Autologous Vaccine for Follicular Lymphoma
PHASE1Completed
28 participants
Started: Jan 31, 2010 · Completed: Oct 31, 2013